Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

TRAVERT 10% IN PLASTIC CONTAINER

INVERT SUGAR

Standard Dose
10GM/100ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TRAVERT 10% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 016717 (NDA).

Marketing status: Discontinued Active ingredient INVERT SUGAR Form and strength INJECTABLE;INJECTION - 10GM/100ML Sponsor BAXTER HLTHCARE Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview TRAVERT 10% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 016717 (NDA). Marketing status: Discontinued Active ingredient INVERT SUGAR Form and strength INJECTABLE;INJECTION - 10GM/100ML Sponsor BAXTER HLTHCARE Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.